Literature DB >> 1590605

Effects of prehospital medications on mortality and length of stay in congestive heart failure.

R C Wuerz1, S A Meador.   

Abstract

HYPOTHESIS: Prehospital medications for congestive heart failure should affect hospital outcomes (survival and length of stay). STUDY
DESIGN: In a retrospective case series, hospital outcomes were compared for patients treated with prehospital nitroglycerin, furosemide, and/or morphine (252) versus those given no medications (241).
SETTING: A rural/suburban emergency medical services system (population 140,000) served by three paramedic units. PARTICIPANTS: Four hundred ninety-three consecutive cases of congestive heart failure or pulmonary edema were identified by hospital discharge diagnosis from a data base of 8,315 paramedic transports with known outcome.
INTERVENTIONS: Oxygen was given by protocol to 489 patients. Other medications were given by order of on-line physician medical command.
RESULTS: Overall mortality was 10.9% (54 of 493). Treated and untreated patients were comparable in age, sex, cardiac rhythms, prior use of cardiac medications, and response and scene times; mortality was reduced in treated versus untreated patients (odds ratio for improved survival, 2.51; 95% confidence interval, 1.37 to 4.55; P less than .01). Positive treatment effect was greatest for 58 nonhypotensive, critical patients (odds ratio for survival, 10.25; P less than .01). No single drug combination was unique in terms of treatment benefit. Patients treated in the field received medications 36 minutes earlier than patients first treated in the emergency department. No survival benefit was evidence for noncritical, nonhypotensive patients, and patients with final diagnoses of asthma, chronic obstructive pulmonary disease, pneumonia, or bronchitis had a higher than expected mortality if erroneously treated for congestive heart failure. Differences in hospital length of stay were not significant for any group.
CONCLUSION: Prehospital medications improve survival in congestive heart failure, especially in critical patients. More than one combination of medications seems effective, and early treatment is associated with improved survival. However, these medications appear to increase mortality in patients misdiagnosed in the field. Factors used in paramedica and medical command assessments require further study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590605     DOI: 10.1016/s0196-0644(05)82777-5

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  26 in total

1.  Correlation between NT proBNP and left ventricular ejection fraction in elderly patients presenting to emergency department with dyspnoea.

Authors:  Amulya C Belagavi; Medha Rao; Aslam Y Pillai; U S Srihari
Journal:  Indian Heart J       Date:  2012 May-Jun

Review 2.  Management of acute decompensated heart failure.

Authors:  Larry A Allen; Christopher M O'Connor
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

3.  Diagnostic and prognostic value of plasma volume status at emergency department admission in dyspneic patients: results from the PARADISE cohort.

Authors:  Tahar Chouihed; Patrick Rossignol; Adrien Bassand; Kévin Duarte; Masatake Kobayashi; Déborah Jaeger; Sonia Sadoune; Aurélien Buessler; Lionel Nace; Gaetan Giacomin; Thibaut Hutter; Françoise Barbé; Sylvain Salignac; Nicolas Jay; Faiez Zannad; Nicolas Girerd
Journal:  Clin Res Cardiol       Date:  2018-10-28       Impact factor: 5.460

4.  The epidemiology and outcome of prehospital respiratory distress.

Authors:  Matthew E Prekker; Laura C Feemster; Catherine L Hough; David Carlbom; Kristina Crothers; David H Au; Thomas D Rea; Christopher W Seymour
Journal:  Acad Emerg Med       Date:  2014-05       Impact factor: 3.451

Review 5.  Management of acute pulmonary edema in the emergency department.

Authors:  Andrea Bellone; Andrea Barbieri; Francesca Bursi; Marco Vettorello
Journal:  Curr Heart Fail Rep       Date:  2006-09

Review 6.  Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance.

Authors:  A Mebazaa; H Tolppanen; C Mueller; J Lassus; S DiSomma; G Baksyte; M Cecconi; D J Choi; A Cohen Solal; M Christ; J Masip; M Arrigo; S Nouira; D Ojji; F Peacock; M Richards; N Sato; K Sliwa; J Spinar; H Thiele; M B Yilmaz; J Januzzi
Journal:  Intensive Care Med       Date:  2015-09-14       Impact factor: 17.440

7.  Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide.

Authors:  Kevin Shah; Garrett J Terracciano; Kevin Jiang; Alan S Maisel; Robert L Fitzgerald
Journal:  West J Emerg Med       Date:  2010-02

Review 8.  The diagnosis of acute congestive heart failure: role of BNP measurements.

Authors:  Alan S Maisel
Journal:  Heart Fail Rev       Date:  2003-10       Impact factor: 4.214

9.  The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea.

Authors:  C Mueller; K Laule-Kilian; A Christ; A P Perruchoud
Journal:  Diabetologia       Date:  2006-02-16       Impact factor: 10.122

10.  Combination of quantitative capnometry, N-terminal pro-brain natriuretic peptide, and clinical assessment in differentiating acute heart failure from pulmonary disease as cause of acute dyspnea in pre-hospital emergency setting: study of diagnostic accuracy.

Authors:  Petra Klemen; Mirjam Golub; Stefek Grmec
Journal:  Croat Med J       Date:  2009-04       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.